Using therapeutic drug monitoring to dose the antimycobacterial drugs

Clinics in Chest Medicine

Volumn 18, Issue 1, 1997, Pages 79-87

  Peloquin, C A ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; ANTIMYCOBACTERIAL AGENT; AZITHROMYCIN; CAPREOMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; OFLOXACIN; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN; THIOACETAZONE;

ANTIBACTERIAL ACTIVITY; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MONITORING; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS;

EID: 0030894777     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70357-9     Document Type: Article

References (26)

1. S.E. Berning G.A. Huitt M.D. Iseman Malabsorption of antituberculosis medications by a patient with AIDS N Engl J Med 327 1992 1817 1818
2. G.W. Comstock L.M. Hammes A. Pio Isoniazid prophylaxis in Alaskan boarding schools: A comparison of two doses Am Rev Respir Dis 100 1969 773 779
3. B. Doster F.J. Murray R. Newman Ethambutol in the initial treatment of pulmonary tuberculosis Am Rev Respir Dis 107 1973 177 190
4. W.E. Evans General principles of applied pharmacokinetics. In: W.E. Evans J.J. Schentag W.J. Jusko Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring ed 3 1992 Applied Therapeutics, Inc. Spokane, WA 1.1 1.8
5. D.J. Girling Adverse effects of antituberculosis drugs Drugs 23 1982 56 74
6. S.M. Gordon C.R. Horsburgh Jr C.A. Peloquin Low serum levels of oral antimycobacterial agents in patients with disseminated Mycobacterium avium complex disease J Infect Dis 168 1993 1559 1562
7. L.B. Heifets Introduction: Drug susceptibility tests and the clinical outcome of chemotherapy L.B. Heifets Drug Susceptibility in the Chemotherapy of Mycobacterial Infections 1991 CRC Press Boca Raton, FL 13 58
8. R.W. Jelliffe P. Maire F. Sattler Adaptive control of drug dosage regimens: Basic foundations, relevant issues, and clinical examples Int J Biomed Comput 36 1994 1
9. J.W. Jenne W.H. Beggs Correlation of in vitro and in vivo kinetics with clinical use of isoniazid, ethambutol, and rifampin Am Rev Respir Dis 107 1973 1013 1021
10. W.J. Jusko Guidelines for the collection and analysis of pharmacokinetic data W.E. Evans J.J. Schentag W.J. Jusko Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring ed 3 1992 Applied Therapeutics, Inc. Spokane, WA 2.1 2.43
11. M. LeBel M. Spino Pulse dosing versus continuous infusion of antibiotics Clin Pharmacokinet 14 1988 71 95
12. M.W. Long D.E. Snider Jr L.S. Farer US Public Health Service cooperative trial of three rifampin–isoniazid regimens in treatment of pulmonary tuberculosis Am Rev Respir Dis 119 1979 879 894
13. K.B. Patel R. Belmonte H.M. Crowe Drug malabsorption and resistant tuberculosis in HIV-infected patients [letter] N Engl J Med 332 1995 336 337
14. C.A. Peloquin Therapeutic drug monitoring of the antimycobacterial drugs Clin Lab Med 16 1996 717 729
15. C.A. Peloquin Therapeutic drug monitoring: Principles and applications in mycobacterial infections Drug Therapy 22 1992 31 36
16. C.A. Peloquin Pharmacology of the antimycobacterial drugs Med Clin North Am 77 1993 1253 1262
17. Peloquin CA: Antimicrobial therapy. In Bittar EE (ed): Principles of Medical Biology. Jai Press Inc., in press
18. C.A. Peloquin Antituberculosis drugs: Pharmacokinetics L.B. Heifets Drug Susceptibility in the Chemotherapy of Mycobacterial Infections 1991 CRC Press Boca Raton, FL 59 88
19. Peloquin CA, Iseman MD: Antimycobacterial agents. In Root RK (ed): Clinical Infectious Diseases: A Practical Approach, in press
20. C.A. Peloquin A.A. MacPhee S.E. Berning Malabsorption of antimycobacterial medications N Engl J Med 329 1993 1122 1123
21. C.A. Peloquin A.T. Nitta W.J. Burman Low anti-tuberculosis drug concentrations in patients with AIDS Ann Pharmacother 30 1996 919 925
22. J. Sahai L. Swick S. Tailor Reduced oral absorption of tuberculosis drugs in HIV infection [abstract PI-51] Clin Pharmacol Ther 59 1996 142
23. M. Turner C. McGowan E. Nardell Serum drug levels in tuberculosis patients [Abstract] Am J Respir Crit Care Med 149 1994 A527
24. L. Verbist Mode of action of antituberculous drugs (Part I) Medicon Int 3 1974 11 23
25. L. Verbist Mode of action of antituberculous drugs (Part II) Medicon Int 3 1974 3 17
26. F.G. Winder Mode of action of the antimycobacterial agents and associated aspects of the molecular biology of the mycobacteria C. Ratledge J. Stanford The Biology of Mycobacteria, vol 1—Physiology, Identification, and Classification 1982 Academic Press London 353 438